Estazolam
NDC Package 49884-112-01
Package Information
Estazolam is a medication used to treat a certain sleep problem (insomnia). Marketed by Par Pharmaceutical Inc., this product is identified by NDC 49884-112 and is authorized under FDA application ANDA074921.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49884 - Par Pharmaceutical Inc.
- 49884-112 - Estazolam
- 49884-112-01 - 100 TABLET in 1 BOTTLE
- 49884-112 - Estazolam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49884-112-01 identifies a specific commercial package of 100 tablet in 1 bottle of Estazolam, labeled by Par Pharmaceutical Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Par Pharmaceutical Inc. on June 30, 2009. The current certification is valid through June 30, 2009.
What are the primary indications for this medication?
This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Estazolam belongs to a class of drugs called benzodiazepines. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment.
How is this Par Pharmaceutical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49884011201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.